Garetosmab
COURAGE
Regeneron · Phase 2 · Active, not recruiting · Enrollment 1005
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| Trevogrumab | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm A0 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm A1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm B0 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm B1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm C0 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm C1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm D0 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm D1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm 3 | Obesity or overweight | n/r | n/r | n/r | n/r |